Pierre Fabre Laboratories is one of Europe's leading pharmaceutical companies. For over 40 years, it has established itself as an international player in oncology, mastering the entire value chain from R&D to marketing. Its portfolio of oncology specialties covers colorectal, breast, lung and skin cancers, as well as certain hematologic malignancies and precancerous dermatological conditions such as actinic keratosis. In 2023, its oncology revenue amounted to nearly 500 million euros, over 90% of which was generated outside France.
In 2023, Pierre Fabre Laboratories posted 2.83 billion euros in revenue, 70% of which came from international sales in 120 countries. Its portfolio includes several international brands and medical franchises such as Pierre Fabre Oncologie, Pierre Fabre Dermatologie, Pierre Fabre Pharma Care, Eau Thermale Avène, Ducray, A-Derma, Klorane, René Furterer and Même Cosmetics.
Historically based in the southwest of France and manufacturing 95% of its products in France, Pierre Fabre Laboratories employs over 10,000 people worldwide. Its annual R&D budget amounts to nearly 200 million euros, of which about 50% is dedicated to targeted therapies in oncology and 40% to skin health and care solutions.
Pierre Fabre Laboratories' majority shareholder (86%) is the eponymous Foundation, which is recognized by the French government as being a public–interest foundation. This capital structure guarantees the company's independence and long-term vision. Dividends paid to the Pierre Fabre Foundation enable it to design and finance humanitarian healthcare-access programs in developing countries. Employees are the company's secondary shareholder, through an international employee shareholding plan.
Pierre Fabre Laboratories’ sustainability policy has been assessed by the independent AFNOR Certification body and has been awarded the "Exemplary" level of its CSR label (ISO 26 000 standard for sustainable development).
Company Details
- Employees
- 60
- Founded
- -
- Address
- Parc Industriel De La Chartreuse, Castres,81100,france
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- https://www.pierre-fabre.com/
- Keywords
- Oncology, Melanoma, CRC, Colorectal Cancer, Lung Cancer, Breast Cancer, PTLD EBV+, Bladder Cancer.
- HQ
- Castres
Pierre Fabre Oncology Questions
Pierre Fabre Oncology's website is https://www.pierre-fabre.com/
Pierre Fabre Oncology's LinkedIn profile is https://fr.linkedin.com/company/pierre-fabre-oncology
Pierre Fabre Oncology has
60 employees.
View email and phone details for 60
employees at Pierre Fabre Oncology.
Pierre Fabre Oncology's industry is
Pharmaceutical Manufacturing
Pierre Fabre Oncology's top competitors are
Roche,
Novartis,
Abbvie,
Servier,
Pierre Fabre Pharmaceuticals (Usa),
Astrazeneca,
Pierre Fabre Dermo-Cosmetique,
Pierre Fabre Laboratories,
Sanofi,
Ipsen.
Pierre Fabre Oncology's categories are Pharmaceutical Manufacturing
Pierre Fabre Oncology's founding year is 1962
